On June 30, 2022, Bridge Biotherapeutics, Inc. closed the transaction. The company issued 292,680 shares for gross proceeds of KRW 2,999,970,000 in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,330 KRW | +10.17% | -43.24% | -29.07% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,830 KRW | -1.44% | +5.73% | 77.03M | ||
3,385 KRW | -.--% | -1.46% | 546M | ||
2,330 KRW | +10.17% | -43.24% | 41M | ||
2,010 KRW | -0.50% | +0.65% | 77.31M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.07% | 41M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.33% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- A288330 Stock
- News Bridge Biotherapeutics, Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 2.99997 billion in funding from a group of investors